Vectura to buy SkyePharma for $620 million as UK biotech consolidates
 

Vectura to buy SkyePharma for $620 million as UK biotech consolidates
LONDON (Reuters) - Respiratory drug specialist Vectura has agreed to buy rival SkyePharma for 441 million pounds ($621 million), in a **table piece of consolidation among Britain's universe of...http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/news...38:V_sGLiPBpWU http://feeds.feedburner.com/~ff/news...38:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/news/...~4/b-9Cf54BU9E